Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

180 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Navigating the Wild West of Medication Adherence Reporting in Specialty Pharmacy.
Canfield SL, Zuckerman A, Anguiano RH, Jolly JA, DeClercq J, Wascher M, Choi L, Knox S, Mitchell DG. Canfield SL, et al. Among authors: declercq j. J Manag Care Spec Pharm. 2019 Oct;25(10):1073-1077. doi: 10.18553/jmcp.2019.25.10.1073. J Manag Care Spec Pharm. 2019. PMID: 31556829 Free PMC article.
Adherence and persistence in patients with rheumatoid arthritis at an integrated health system specialty pharmacy.
Peter ME, Zuckerman AD, DeClercq J, Choi L, James C, Cooper K, Choi J, Nadler M, Tanner SB. Peter ME, et al. Among authors: declercq j. J Manag Care Spec Pharm. 2021 Jul;27(7):882-890. doi: 10.18553/jmcp.2021.27.7.882. J Manag Care Spec Pharm. 2021. PMID: 34185565 Free PMC article.
Findings support evidence that integrated health-system specialty pharmacies with clinical pharmacists embedded in outpatient clinics help patients overcome barriers to medication adherence to persist on therapy. DISCLOSURES: This study was funded by Sanofi, Inc. James and J …
Findings support evidence that integrated health-system specialty pharmacies with clinical pharmacists embedded in outpatient clinics help p …
A cross-sectional analysis of persistence to disease-modifying therapies in treatment naïve and experienced patients with relapsing multiple sclerosis at a health-system specialty pharmacy.
Kozlicki MZ, Markley B, Shah NB, DeClercq J, Choi L, Zuckerman AD. Kozlicki MZ, et al. Among authors: declercq j. Mult Scler Relat Disord. 2022 Jul;63:103860. doi: 10.1016/j.msard.2022.103860. Epub 2022 May 10. Mult Scler Relat Disord. 2022. PMID: 35609353 Free article.
180 results